Commission Delegated Regulation (EU) 2020/688 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs (Text with EEA relevance) (Text with EEA relevance)
Modified by
- Commission Delegated Regulation (EU) 2021/1706of 14 July 2021amending and correcting Delegated Regulation (EU) 2020/688 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs(Text with EEA relevance), 32021R1706, September 24, 2021
- Commission Delegated Regulation (EU) 2023/118of 23 September 2022amending Delegated Regulation (EU) 2020/688 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of captive birds intended for exhibitions(Text with EEA relevance), 32023R0118, January 18, 2023
- Commission Delegated Regulation (EU) 2023/2515of 8 September 2023amending Delegated Regulation (EU) 2020/688 as regards certain animal health requirements for movements within the Union of terrestrial animals(Text with EEA relevance), 32023R2515, November 14, 2023
(a) kept and wild terrestrial animals and hatching eggs; (b) establishments where those animals and hatching eggs are kept or undergo assembly operations; (c) operators keeping those animals and hatching eggs; (d) operators transporting terrestrial animals and hatching eggs; (e) competent authorities of Member States.
(1) "means of transport" means road or rail vehicle, vessels and aircrafts; (2) "container" means any crate, box, receptacle or other rigid structure used for the transport of animals or eggs which is not the means of transport; (3) "environmentally isolated production establishment" means an establishment where its structures together with its strict biosecurity measures, ensure an effective isolation of the production of animals from the associated facilities and from the environment; (4) "bovine animal" means an animal of the species of ungulates belonging to the genera Bison ,Bos (including the subgeneraBos ,Bibos ,Novibos ,Poephagus ) andBubalus (including the subgenusAnoa ) and the offspring of crossings of those species;(5) "establishment free from "disease" " means an establishment granted the disease-free status in accordance with the requirements set out in Delegated Regulation (EU) 2020/689; (6) "status free from "disease" " means a disease-free status of a Member State or a zone thereof as approved by the Commission in accordance with Article 36 of Regulation (EU) 2016/429; (7) " "disease" " has not been reported’ means that no animal or group of animals of relevant species kept on the establishment has been classified as a confirmed case of that disease and any suspect case of that disease has been ruled out; (8) " "animals" intended for slaughter" means kept terrestrial animals to be transported, either directly or after undergoing an assembly operation, to a slaughterhouse; (9) "approved quarantine establishment" means an establishment granted the approval in accordance with Article 14 of Delegated Regulation (EU) 2019/2035; (10) "approved eradication programme" means a disease eradication programme implemented in a Member State or zone thereof as approved by the Commission in accordance with Article 31(3) of Regulation (EU) 2016/429; (11) "ovine animal" means an animal of the species of ungulates belonging to the genus Ovis and the offspring of crossings of those species;(12) "caprine animal" means an animal of the species of ungulates belonging to the genus Capra and the offspring of crossings of those species;(13) "porcine animal" means an animal of the species of ungulates belonging to the family Suidae listed in Annex III to Regulation (EU) 2016/429;(14) "equine animal" means an animal of species of solipeds belonging to the genus Equus (including horses, asses, and zebras) and the offspring of crossings of those species;(15) "camelid animal" means an animal of the species of ungulates belonging to the family Camelidae listed in Annex III to Regulation (EU) 2016/429;(16) "cervid animal" means an animal of the species of ungulates belonging to the family Cervidae listed in Annex III to Regulation (EU) 2016/429;(17) "other kept ungulates" means kept ungulates other than bovine, ovine, caprine, porcine, equine, camelid and cervid animals; (18) "vector protected establishment" means part or all facilities of an establishment that are protected against attacks from Culicoides by appropriate physical and management means, with a status of vector protected establishment granted by the competent authority in accordance with Article 44 of Delegated Regulation (EU) 2020/689. (19) "vector-free period" means in a defined area the period of inactivity of Culicoides determined in accordance with Section 5 of Chapter 1 of Part II of Annex V to Delegated Regulation (EU) 2020/689.(20) "breeding poultry" means poultry 72 hours old or more, intended for the production of hatching eggs; (21) "productive poultry" means poultry 72 hours old or more, reared for the production of meat, eggs for consumption or other products or for restocking supplies of game birds; (22) "flock" means all poultry or captive birds of the same health status kept on the same premises or in the same enclosure and constituting a single epidemiological unit; in housed poultry, this includes all birds sharing the same airspace; (23) "day-old chicks" means all poultry less than 72 hours old; (24) "specified pathogen-free eggs" means hatching eggs derived from "chicken flocks free from specified pathogens", as described in the European Pharmacopoeia http://www.edqm.eu (latest edition). (25) "registered equine animal" means: (a) a purebred breeding animal of the species Equus caballus andEquus asinus entered or eligible for entry in the main section of a breeding book established by a breed society or breeding body recognised in accordance with Articles 4 or 34 of Regulation (EU) 2016/1012;(b) a kept animal of the species Equus caballus registered with an international association or organisation, either directly or through its national federation or branches, which manages horses for competition or racing ("registered horse");
(26) "primates" means animals of the species belonging to the order Primates excluding humans; (27) "honeybee" means an animal of the Apis mellifera species;(28) "bumble bee" means an animal of the species belonging to the genus Bombus ;(29) "dog" means a kept animal of the Canis lupus species;(30) "cat" means a kept animal of the Felis silvestris species;(31) "ferret" means a kept animal of the Mustela putorius furo species;(32) "other carnivores" means animals of the species belonging to the order Carnivora other than dogs, cats and ferrets; (33) "travelling circus" means an exhibition or fair that includes animals or animal acts which is intended to move between Member States; (34) "animal act" means any act featuring animals kept for the purpose of an exhibition or fair, and which may form part of a circus; (35) "racing pigeon" means any pigeon transported or intended for transport from its pigeon house to another Member State in order to be released to fly back to the Member State of origin;
(a) constructed in such a way that (i) animals or hatching eggs cannot escape or fall out; (ii) visual inspection of the space where animals are kept is possible; (iii) the escape of animal excrements, litter or feed is prevented or minimised; (iv) in the case of poultry and captive birds, the escape of feathers is prevented or minimised;
(b) cleaned and disinfected as soon as possible after every transport of animals, hatching eggs or any item representing an animal health risk, and, if necessary, cleaned and disinfected again and in any case dried or allowed to dry before any new loading of animals or hatching eggs.
(a) comply with the requirements in Article 4(a); (b) contain only animals or hatching eggs of the same species, category and type, and of the same health status; (c) are: (i) either unused and purpose-designed disposable containers to be destroyed after first use; or (ii) cleaned and disinfected after use and dried or allowed to dry before any subsequent use.
(a) for day-old chicks and hatching eggs: (i) the name of the Member State of origin; (ii) the approval or registration number of the establishment of origin; (iii) the species of poultry concerned; (iv) the number of animals or hatching eggs;
(b) for breeding poultry and productive poultry, the approval or registration number of the establishment of origin.
(a) terrestrial animals kept in travelling circuses and animal acts; (b) animals of the species listed in Part A of Annex I to Regulation (EU) 2016/429 in numbers exceeding those authorised in accordance with Article 246(1) and (2) of that Regulation, if they are transported for non-commercial purposes; (c) animals of species listed in Part B of Annex I to Regulation (EU) 2016/429 transported for non-commercial purposes in numbers exceeding those set for those species where rules setting the maximum number of pet animals of the species concerned have been adopted in accordance with Article 246(3).
(a) within an establishment when (i) the transported animals are kept on the establishment and the transport is carried out by the operator of that establishment; and (ii) the means of transport used for transporting kept terrestrial animals are cleaned and disinfected before leaving the establishment;
or (b) between establishments within the Member State when (i) the establishments belong to the same supply chain; and (ii) the means of transport used for transporting kept terrestrial animals are cleaned and disinfected by the end of each day if animals have been transported in these means of transport.
(a) they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V Delegated Regulation (EU) 2020/689; or (b) they fulfil the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689 that were agreed by the competent authority of the Member State of destination.
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept bovine animals of a lower health status or subject to movement restrictions for animal health reasons or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) the animals come from an establishment free from infection with Brucella abortus, B. melitensis andB. suis without vaccination regarding bovine animals, and one of the following conditions is fulfilled:(i) the establishment is situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis andB. suis regarding the bovine population;or (ii) the animals have been subjected to a test for infection with Brucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females taken at least 30 days after parturition;or (iii) the animals are less than 12 months old; or (iv) the animals are castrated;
(d) the animals come from an establishment free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ), and at least one of the following conditions is fulfilled:(i) the establishment is situated in a Member State or zone thereof with the status free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis );or (ii) the animals have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) with one of the diagnostic methods provided for in Part 2 of Annex I, carried out, with negative results, during the last 30 days prior to departure;or (iii) the animals are less than 6 weeks old;
(e) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (f) the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus: (i) has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure; or (ii) has been reported in kept animals of listed species for that disease during the last 2 years prior to departure but one of the following set of requirements is complied with: 1. the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the entry date of the animal into the seasonally disease-free area; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the entry date of the animal into the seasonally disease-free area; or
2. the animals have been protected against attacks by the vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors.
(g) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (h) the animals come from an establishment in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, and in case they come from an establishment in which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restrictions until:(i) the infected animals have been removed from the establishment; and (ii) the remaining animals on the establishment have been subjected to a test for surra ( Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;
(i) except in the case of kept bovine animals referred to in Articles 11(4), 12(4) and Article 13, the animals fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689; (j) the conditions set out in Articles 32 and 33 are fulfilled where applicable.
(a) has informed the Commission and the other Member States that such movements are authorised; and (b) accepts the animals regardless of the Member State or area thereof of their origin.
(a) the animals come from an establishment free from enzootic bovine leukosis; or (b) if the animals come from an establishment that is not free from enzootic bovine leukosis, then enzootic bovine leukosis has not been reported in that establishment during the last 24 months prior to departure, and (i) if the animals are over 24 months of age, they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out with negative results either on samples taken on two occasions at an interval of at least four months while kept in isolation from the other bovine animals of the establishment; or on a sample taken during the last 30 days prior to their departure, and all bovine animals over 24 months kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals;
or (ii) in case the animals are less than 24 months of age, they were born to dams, which have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals.
(a) if the animals come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, either (i) the establishment is situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis; or (ii) the animals have been subject to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, carried out on a sample taken during the last 15 days prior to their departure;
(b) if the animals come from an establishment not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, they have been kept in an approved quarantine establishment for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, carried out on a sample taken not less than 21 days after commencement of the quarantine.
(a) if the animals come from an establishment free from bovine viral diarrhoea, (i) the establishment is either situated in a Member State or zone thereof with the status free from bovine viral diarrhoea or has been subject to a testing regime as referred in point 1(c) (ii) or (iii) of Section 2 of Chapter 1 of Part VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last four months prior to departure of the animals; or (ii) the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to their departure;
(b) if the animals come from an establishment not free from bovine viral diarrhoea, they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I, carried out with negative results, and either (i) the animals have been kept in an approved quarantine establishment for a period of at least 21 days prior to their departure and, in case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results, on samples taken not less than 21 days after commencement of the quarantine; or (ii) the animals have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, with positive results, carried out on samples taken either prior to departure or, in case of pregnant dams, before insemination preceding the current gestation.
(a) the animals come from an establishment free from enzootic bovine leukosis; or (b) if the animals come from an establishment that is not free from enzootic bovine leucosis, enzootic bovine leukosis has not been reported in that establishment during the last 24 months prior to departure of the animals, and (i) in case the animals are over 24 months of age, they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, either on samples taken on two occasions at an interval of at least four months while kept in isolation from the other bovine animals of the establishment; or on samples taken during the last 30 days prior to their departure, provided that all bovine animals over 24 months kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of at least four months during the last 12 months prior to the departure of the animals;
or (ii) in case the animals are less than 24 months of age, they were born to dams, which have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals.
(a) if the animals come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, either (i) the establishment is situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis; or (ii) the establishment is situated in a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis; or (iii) the animals have been subject to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1 or, in case of animals vaccinated with a gE-deleted vaccine, antibodies against the BoHV-1 gE protein, with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure; or (iv) the animals are destined for an establishment which keeps bovine animals for meat production without contact to bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;
or (b) if the animals come from an establishment not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, they have been kept in an approved quarantine establishment for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1 with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, on a sample taken not less than 21 days after commencement of the quarantine.
(a) if the animals come from an establishment free from bovine viral diarrhoea, (i) the establishment is situated in a Member State or zone thereof with the status free from bovine viral diarrhoea; or (ii) the establishment is situated in a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea; or (iii) the establishment has been subject to a testing regime as referred in point 1(c) (ii) or (iii) of Section 2 of Chapter 1 of Part VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last four months prior to departure; or (iv) the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to departure; or (v) the animals are destined for an establishment which keeps bovine animals for meat production separate from bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;
(b) if the animals come from an establishment not free from bovine viral diarrhoea, they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results, and (i) the animals either have been kept in an approved quarantine establishment for a period of at least 21 days prior to their departure and, in case of pregnant dams, were subjected to a serological test for the detection of antibodies against the bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results, on samples taken not less than 21 days after commencement of the quarantine; or (ii) the animals were subjected to a serological test for the detection of antibodies against the bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, with positive results, carried out on samples taken either prior to departure or, in case of pregnant dams, before the insemination preceding the current gestation.
(a) the animals either (i) come from an establishment free from infection with Brucella abortus, B. melitensis andB. suis with or without vaccination regarding bovine animals;or (ii) are castrated; or (iii) are entire bovine animals older than 12 months of age and have been subjected to a test for infection with Brucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females on a sample taken at least 30 days after parturition;
(b) the animals either (i) come from an establishment free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis );or (ii) have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) with one of the diagnostic methods provided for in Part 2 of Annex I, carried out, with negative results, during the last 30 days prior to departure;
(c) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (e) the animals come from an establishment in which infection with Bluetongue virus (serotypes 1-24) has not been reported during the last 30 days prior to departure.
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept ovine or caprine animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) except when they are moved in accordance with Article 16, they come from an establishment free from infection with Brucella abortus, B. melitensis andB. suis without vaccination regarding ovine and caprine animals, andeither (i) the establishment is situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis andB. suis regarding the ovine and caprine population;or (ii) the animals have been subjected to a test for infection with Brucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females, taken at least 30 days after parturition;or (iii) the animals are less than 6 months old; or (iv) the animals are castrated.
(d) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (e) the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus: (i) has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure; or (ii) has been reported in kept animals of listed species for that disease during the last 2 years prior to departure but one of the following set of requirements is complied with: 1. the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the entry date of the animal into the seasonally disease -free area; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the entry date of the animal into the seasonally disease-free area; or
2. the animals have been protected against attacks by the vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors.
(f) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (g) the animals come from an establishment in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, and in case they come from an establishment in which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restrictions until:(i) the infected animals have been removed from the establishment; and (ii) the remaining animals on the establishment have been subjected to a test for surra ( Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;
(h) except when the animals are moved in accordance with Article 17, they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689; (i) the conditions set out in Articles 32 and 33 are fulfilled where applicable.
(a) has informed the Commission and the other Member States that such movements are authorised; and (b) accepts the animals regardless of the Member State or area thereof of their origin.
(i) only caprine animals from establishments applying the measures provided for in this paragraph have been introduced in the establishment referred to in paragraph 1(a); (ii) in case infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) has been reported in caprine animals kept on the establishment, measures were taken in accordance with Part 1(3) of Annex II.
(a) the animals come from an establishment in which ovine epididymitis ( Brucella ovis ) has not been reported during the last 12 months prior to departure;(b) the animals have been subjected to a serological test for ovine epididymitis ( Brucella ovis ), carried out, with negative results, on a sample taken during the last 30 days prior to departure.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) the animals are either individually identified in accordance with Article 45 of Delegated Regulation (EU) 2019/2035, or alternatively, they have been continuously resident in the establishment for at least 21 days prior to departure, or since birth, if they are younger than 21 days of age; (b) the animals either (i) come from an establishment free from infection with Brucella abortus, B. melitensis andB. suis with or without vaccination regarding ovine and caprine animals;or (ii) are older than 6 months of age and have been subjected to a test for infection with Brucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females taken at least 30 days after parturition;or (iii) are castrated;
(c) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (e) the animals come from an establishment in which infection with Bluetongue virus (serotypes 1-24) has not been reported during the last 30 days prior to departure..
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept porcine animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) the animals come from an establishment in which infection with Aujeszky’s disease virus has not been reported during the last 30 days prior to departure; (e) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (f) the animals come from an establishment in which infection with Brucella abortus, B. melitensis andB. suis in porcine animals has not been reported during the last 42 days prior to departure, and in which during at least the last 12 months prior to departureeither (i) biosecurity and risk mitigating measures, including housing conditions and feeding systems, have been applied as necessary to prevent transmission of infection with Brucella abortus, B. melitensis andB. suis from wild animals of listed species for that disease to porcine animals kept on the establishment, and only porcine animals from establishments applying equivalent biosecurity and risk mitigating measures have been introduced;or (ii) surveillance for infection with Brucella abortus, B. melitensis andB. suis has been carried out on the porcine animals kept on the establishment in accordance with point 1 and point 2 of Annex III during at least the last 12 months prior to departure, and during this periodonly porcine animals from establishments applying the measures provided for in point (i) or in this point have been introduced in the establishment referred to in point (a); in case infection with Brucella abortus, B. melitensis andB. suis has been reported in porcine animals kept on the establishment, measures were taken in accordance with point 3 of Annex III.
(a) if the animals come from an establishment free from infection with Aujeszky’s disease virus, either (i) the establishment is situated in a Member State or zone thereof with the status free from infection with Aujeszky’s disease virus; or (ii) the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus with the diagnostic method provided for in Part 7 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure. For porcine animals less than four months old born to dams vaccinated with a gE-deleted vaccine, the diagnostic method for the detection of antibodies against Aujeszky’s disease virus gE protein provided for in Part 7 of Annex I may be used. The number of porcine animals tested must allow at least for the detection of 10 % seroprevalence of the consignment with 95 % confidence;
(b) if the animals come from an establishment not free from infection with Aujeszky’s disease virus, the following requirements are fulfilled: (i) the animals have been kept in an approved quarantine establishment for a period of at least 30 days; and (ii) the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus with the diagnostic method provided for in Part 7 of Annex I, with a negative result, carried out on samples taken on two occasions at an interval of not less than 30 days, the last sample taken during the last 15 days prior to departure.
(a) if the animals come from an establishment free from infection with Aujeszky’s disease virus, either (i) the establishment is situated in a Member State or zone thereof with the status free from infection with Aujeszky’s disease virus; or (ii) the establishment is situated in a Member State or zone thereof with an approved eradication programme for infection with Aujeszky’s disease virus; or (iii) the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus or antibodies against Aujeszky’s disease virus-gE protein, where applicable, with one of the diagnostic methods provided for in Part 7 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure. The number of porcine animals tested must allow at least for the detection of 10 % seroprevalence of the consignment with 95 % confidence;
(b) if the animals come from an establishment not free from infection with Aujeszky’s disease virus the following requirements are fulfilled: (i) they have been kept in an approved quarantine establishment for a period of at least 30 days; and (ii) they have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus or antibodies against Aujeszky’s disease virus gE protein, where applicable, with one of the diagnostic methods provided for in Part 7 of Annex I, with a negative result, carried out on samples taken on two occasions at an interval of not less than 30 days, the last sample taken during the last 15 days prior to departure.
(a) in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (b) in which anthrax in ungulates has not been reported during the last 15 days prior to departure.
(a) the animals come from an establishment in which infection with Aujeszky’s disease virus has not been reported during the last 30 days prior to departure; (b) the animals are transported directly to the slaughterhouse in the Member State of destination without undergoing any assembly operations in that Member State or zone thereof, or any Member State or zone thereof of passage with the status free from infection with Aujeszky’s disease virus.
(a) the animals come from an establishment in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, or in case they come from an establishment in which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:(i) the infected animals have been removed from the establishment, and (ii) the remaining animals in the establishment have been subjected to a test for surra ( Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the last infected animal has been removed from the establishment;
(b) the animals come from an establishment in which dourine has not been reported during the last 6 months prior to departure, or in case they come from an establishment in which dourine has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until: (i) the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated; and (ii) the remaining equine animals in the establishment, with the exception of the castrated male equine animals referred to in point (i), have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I, carried out, with negative results, on samples taken at least 6 months after the measures described in point (i) have been completed;
(c) the animals come from an establishment in which equine infectious anaemia has not been reported during the last 90 days prior to departure, or in case they come from an establishment in which equine infectious anaemia has been reported during the last 12 months prior to departure, following the last outbreak the affected establishment has remained under movement restriction until: (i) the infected animals have been killed and destroyed or slaughtered and the establishment was cleaned and disinfected; and (ii) the remaining animals in the establishment have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the measures described in point (i) have been completed;
(d) the animals come from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to departure, or in case they come from an establishment situated in a Member State or zone thereof in which Venezuelan equine encephalomyelitis has been reported during the last 2 years, they comply with the conditions in point (i) and the conditions in either point (ii) or point (iii): (i) during the period of at least 21 days prior to departure they have remained clinically healthy and any animal referred to in point (ii) or point (iii) which showed a rise in body temperature above physiological range, taken daily, have been subjected to a diagnostic test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (a) of Part 10(1) of Annex I, with negative results; and (ii) the animals were kept in quarantine for a period of at least 21 days protected from attacks by insect vector, and either have been vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer’s recommendations not less than 60 days and not more than 12 months prior to the date of dispatch; or have been subjected to a test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (b) of Part 10(1) of Annex I, carried out, with negative results, on a sample taken not less than 14 days after the date of entry into quarantine;
(iii) the animals have been subjected to a test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (b) of Part 10(1) of Annex I, without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during a period of 10 days prior to the date of departure; and a test for the detection of Venezuelan equine encephalomyelitis virus genome with the diagnostic method provided for in Part 10(2) of Annex I, with negative result, carried out on a sample taken within 48 hours prior to departure, and the animals have been protected from attacks by insect vectors after sampling until departure;
(e) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (f) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (g) the animals have not been in contact with kept animals of listed species for the diseases referred to in points (a) to (f) which did not comply with the requirements in points (a) to (e) during the last 30 days prior to departure, and with the requirement in point (f) during the last 15 days prior to departure.
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept camelid animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) the animals come from an establishment in which infection with Brucella abortus, B. melitensis andB. suis in camelid animals has not been reported during the last 42 days prior to departure, and they have been subjected to a test for infection withBrucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females taken at least 30 days after parturition;(e) the animals come from an establishment in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ) has been carried out on the camelid animals kept on the establishment in accordance with point (1) and point (2) of Part 2 of Annex II during at least the last 12 months prior to departure, and during this period(i) only camelid animals from establishments applying the measures provided for in this point have been introduced in the establishment referred to in point (a); (ii) in case infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) has been reported in camelid animals kept on the establishment, measures were taken in accordance with point 3 of Part 2 of Annex II.
(f) in case the animals are moved to a Member State or zone thereof with disease-free status or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals, they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in camelid animals has not been reported during the last 30 days prior to departure; (g) the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus: (i) has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure; or (ii) has been reported in kept animals of listed species for that disease during the last 2 years prior to departure but one of the following set of requirements is complied with: 1. the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the entry date of the animal into the seasonally disease-free area; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the entry date of the animal into the seasonally disease-free area; or
2. the animals have been protected against attacks by the vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX: for at least 60 days prior to the date of movement: or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors.
(h) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (i) the animals come from an establishment in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:(i) the infected animals have been removed from the establishment; and (ii) the remaining animals on the establishment have been subjected to a test for surra ( Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;
(j) except when the animals are moved in accordance with Article 24, they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689; (k) the conditions set out in Articles 32 and 33 are fulfilled where applicable.
(a) has informed the Commission and the other Member States that such movements are authorised; and (b) accepts the animals regardless of the Member State or area thereof of their origin.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (b) in which anthrax in ungulates has not been reported during the last 15 days prior to departure. (c) in which infection with Bluetongue virus (serotypes 1-24) has not been reported during the last 30 days prior to departure.
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept cervid animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) the animals come from an establishment in which infection with Brucella abortus, B. melitensis andB. suis in cervid animals has not been reported during the last 42 days prior to departure;(e) the animals come from an establishment in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ) has been carried out on the cervid animals kept on the establishment in accordance with point (1) and point (2) of Part 3 of Annex II during at least the last 12 months prior to departure, and during this period(i) only cervid animals from establishments applying the measures provided for in this point have been introduced in the establishment referred to in point (a); (ii) in case infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) has been reported in cervid animals kept on the establishment, measures were taken in accordance with point (3) of Part 3 of Annex II;
(f) in case the animals are moved to a Member State or zone thereof with disease-free status or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals, they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in cervid animals has not been reported during the last 30 days prior to departure; (g) the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus: (i) has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure; or (ii) has been reported in kept animals of listed species for that disease during the last 2 years prior to departure but one of the following set of requirements is complied with: 1. the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the entry date of the animal into the seasonally disease-free area; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the entry date of the animal into the seasonally disease-free area; or
2. the animals have been protected against attacks by the vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX: for at least 60 days prior to the date of movement: or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors.
(h) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (i) the animals come from an establishment in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:(i) the infected animals have been removed from the establishment; and (ii) the remaining animals on the establishment have been subjected to a test for surra ( Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;
(j) except when they are moved in accordance with Article 27, they comply with at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689; (k) the conditions set out in Articles 32 and 33 are fulfilled where applicable.
(a) has informed the Commission and the other Member States that such movements are authorised; and (b) accepts the animals regardless of the Member State or area thereof of their origin.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (b) in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (c) in which no infection with Bluetongue virus (serotypes 1-24) has been reported during the last 30 days prior to departure.
(a) the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with other kept ungulates of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment; (c) in the case of other kept ungulates of listed species for infection with rabies virus, the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (d) in the case of other kept ungulates of listed species for infection with Brucella abortus, B. melitensis andB. suis , they come from an establishment in which infection withBrucella abortus, B. melitensis andB. suis in other kept ungulates of listed species for this disease has not been reported during the last 42 days prior to departure;(e) in the case of other kept ungulates of listed species for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ), they come from an establishment in which infection withMycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis ) in kept animals of listed species for this disease has not been reported during the last 42 days prior to departure;(f) the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus: (i) has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure; or (ii) has been reported in kept animals of listed species for that disease during the last 2 years prior to departure but one of the following set of requirements is complied with: 1. the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX: for at least 60 days prior to the date of movement; or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the entry date of the animal into the seasonally disease-free area; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the entry date of the animal into the seasonally disease-free area; or
2. the animals have been protected against attacks by the vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX: for at least 60 days prior to the date of movement: or for at least 28 days prior to the date of movement and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors; or for at least 14 days prior to the date of movement and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors.
(g) the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (h) in the case of other kept ungulates of listed species for surra ( Trypanosoma evansi ), they come from an establishment in which surra (Trypanosoma evansi ) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi ) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:(i) the infected animals have been removed from the establishment; and (ii) the remaining animals on the establishment have been tested with one of the diagnostic methods provided for in Part 3 of Annex I for surra ( Trypanosoma evansi ), carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;
(i) in the case of other kept ungulates of listed species for infection with Bluetongue virus (serotype 1-24), they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689. This point shall not apply to other kept ungulates referred to in Article 30. (j) the conditions set out in Articles 32 and 33 are fulfilled where applicable.
(a) has informed the Commission and the other Member States that such movements are authorised; and (b) accepts the animals regardless of the Member State or area thereof of their origin.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) when those animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure; (b) in the case of other kept ungulates of listed species for infection with rabies, when those animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure; (c) in the case of other kept ungulates of listed species for infection with Bluetongue virus (serotypes 1-24), when those animals come from an establishment in which infection with Bluetongue virus (serotypes 1-24) has not been reported during the last 30 days prior to departure.
(a) the transport takes place in a Member State or zone thereof with the status free from infection with Bluetongue virus (serotypes 1-24); (b) the animals are protected from attacks by vectors; and (i) the planned journey does not include the unloading of the animals for a period longer than one day; or (ii) the animals are unloaded in a vector protected establishment; or (iii) the animals are unloaded in a Member State or a zone thereof during the vector-free period;
(c) the animals (i) have been vaccinated against all the serotypes of Bluetongue virus (serotypes 1-24) reported during the last two years in the Member State or zone thereof of passage and they are still within the immunity period of time guaranteed in the specifications of the vaccine; or (ii) were subjected with positive results to a serological test able to detect specific antibodies against all serotypes of Bluetongue virus (serotypes 1-24) reported in the Member State or zone thereof of passage during the last two years prior to departure;
(d) the animals are intended for slaughter.
(a) the animals fulfil the specific animal health requirements defined by the competent authority of destination to ensure the animals, prior to departure, have sufficient immunological protection as regards all serotypes of Bluetongue virus (serotypes 1-24) reported in the Member State or zone thereof of passage during the last two years prior to departure; or (b) the animals fulfil the requirements laid down in point (a) of this paragraph or in point (c) of paragraph 1 in order to ensure they are protected against the serotypes of Bluetongue virus reported in the Member State or zone thereof of passage during the last two years prior to departure and not reported in the Member State or zone of destination during the same period.
(a) the animals fulfil at least one of one of the requirements set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689; or (b) the means of transport where the animals are loaded have been protected from attacks by vectors during transport; and (i) the planned journey does not include the unloading of the animals for a period longer than one day; or (ii) the animals are unloaded in a vector protected establishment or during the vector-free period.
(a) the animals have been continuously resident in one or more approved establishments keeping poultry: (i) since hatching: or (ii) for at least: 42 days prior to departure, in the case of breeding poultry and productive poultry for the production of meat, eggs for consumption or other products; or 21 days prior to departure, in the case of productive poultry for restocking supplies of game birds;
(b) the animals come from a flock in which infection with Salmonella Pullorum,S. Gallinarum andS. arizonae has not been reported and those animals come from establishments which, in case of confirmation of infection withSalmonella Pullorum,S. Gallinarum andS. arizonae during the last 12 months prior to departure have applied the following measures:(i) the infected flock has been slaughtered or it has been killed and destroyed; (ii) following the slaughter or killing of the infected flock referred to in point (i), the establishment has been cleaned and disinfected; (iii) following the cleaning and disinfection referred to in point (ii), all flocks on the establishment tested negative for infection with Salmonella Pullorum,S. Gallinarum andS. arizonae in two tests performed with an interval of at least 21 days in accordance with the surveillance programme referred to in Article 8(b) of Delegated Regulation (EU) 2019/2035;
(c) the animals come from a flock in which avian mycoplasmosis ( Mycoplasma gallisepticum andM. meleagridis ) has not been reported and those animals come from establishments which in case of confirmation of avian mycoplasmosis (Mycoplasma gallisepticum andM. meleagridis ) during the last 12 months prior to departure have applied the following measures:either (i) the infected flock tested negative for avian mycoplasmosis ( Mycoplasma gallisepticum andM. meleagridis ) in two tests performed in accordance with the surveillance programme referred to in Article 8(b) of Delegated Regulation (EU) 2019/2035 on the entire flock with an interval of at least 60 days;or (ii) the infected flock has been slaughtered or it has been killed and destroyed, the establishment has been cleaned and disinfected and following the cleaning and disinfection all flocks on the establishment tested negative for avian mycoplasmosis ( Mycoplasma gallisepticum andM. meleagridis ) in two tests performed with an interval of at least 21 days in accordance with the surveillance programme referred to in Article 8(b) of Delegated Regulation (EU) 2019/2035;
(d) the animals come from flocks which show no clinical signs or suspicion of listed diseases relevant for the species; (e) the surveillance provided for in Article 3(1) of Delegated Regulation (EU) 2020/689 has not detected any confirmed case of infection with low pathogenic avian influenza viruses in the flock of origin of the animals during the last 21 days prior to departure; (f) in the case of productive poultry for restocking supplies of game birds, the animals have had no contact with birds of lower health status during the last 21 days prior to departure; (g) in the case of ducks and geese, the animals have been subjected to a test for highly pathogenic avian influenza according to Annex IV, with negative results; (h) the relevant requirements related to vaccination as provided for in Article 41 and 42 for the specific category of poultry.
(a) the animals have been continuously resident in a registered or approved establishment keeping poultry: (i) since hatching; or (ii) for at least the last 21 days prior to departure;
(b) the animals come from flocks which show no clinical signs or suspicion of listed diseases relevant for the species; (c) the relevant requirements related to vaccination as provided for in Article 41 and 42 for the specific category of poultry.
(a) the animals come from an approved hatchery; (b) the animals have been hatched from hatching eggs which: (i) fulfil the requirements of Article 38 and originate from flocks which have been subjected to checks in accordance with Article 91(1)(f) and Article 91(2)(f); or (ii) have entered into the Union from a third country or territory or zone thereof;
(c) the relevant requirements related to vaccination as provided for in Article 41 and 42 for the specific category of poultry.
(a) the animals come from flocks which have been continuously resident in a single registered establishment since hatching or for at least 21 days prior to departure; (b) the animals come from flocks which show no clinical signs or suspicion of listed diseases relevant for the species; (c) the surveillance provided for in Article 3(1) of Delegated Regulation (EU) 2020/689 has not detected any confirmed case of infection with low pathogenic avian influenza viruses in the flock of origin of the animals during the last 21 days prior to departure; (d) the animals have had no contact with newly-arrived poultry or with birds of lower health status during the last 21 days prior to departure; (e) in the case of ducks and geese, except those intended for slaughter, the animals have been subjected to a test for highly pathogenic avian influenza according to Annex IV, with negative results; (f) the animals have been subjected to tests for infection with Salmonella Pullorum,S. Gallinarum andS. arizonae and for avian mycoplasmosis (Mycoplasma gallisepticum andM. meleagridis) in accordance with Annex V, with negative results;(g) the relevant requirements related to vaccination as provided for in Article 41 and 42 for the specific category of poultry.
(a) they come from an approved establishment; (b) they come from flocks which have been continuously resident in one or more approved establishments keeping poultry since hatching or for at least the last 42 days prior to the collection of the eggs; (c) they come from animals which fulfil the requirements in Article 34(1)(b), (c) and (d); (d) they are individually marked with the approval number of the establishment of the flock of origin referred to in Article 21(a) of Delegated Regulation (EU) 2019/2035; (e) they have been disinfected; (f) the relevant requirements related to vaccination as provided for in Articles 41 and 42.
(a) they come from a registered establishment; (b) they come from flocks which: (i) have been continuously resident in a registered establishment since hatching, or for at least 21 days prior to the collection of the eggs; (ii) show no clinical signs or suspicion of listed diseases relevant for the species; (iii) have been subjected to tests for infection with Salmonella Pullorum,S. Gallinarum andS. arizonae and for avian mycoplasmosis (Mycoplasma gallisepticum andM. meleagridis ) in accordance with Annex V, with negative results;
(c) the relevant requirements related to vaccination as provided for in Article 41 and 42.
(a) they come from an approved establishment keeping poultry; (b) they come from flocks which are free from specified pathogens as described in the European Pharmacopoeia and the results of all tests and clinical examinations required for this specific status have been favourable; (c) they are marked individually with the approval number of the establishment of origin referred to in Article 21(a) of Delegated Regulation (EU) 2019/2035.
(a) in the case of breeding poultry and productive poultry, they: (i) are not vaccinated against infection with Newcastle disease virus; (ii) have been isolated for 14 days prior to departure, at either the establishment of origin under the supervision of an official veterinarian or in an approved quarantine establishment, where: no poultry has been vaccinated against infection with Newcastle disease virus during the last 21 days prior to departure; no other birds were introduced during the last 21 days prior departure; no vaccination has been carried out in the quarantine establishment;
(iii) have tested negative, during the last 14 days prior to departure, in serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95 % confidence of detecting infection at 5 % prevalence;
(b) in the case of poultry intended for slaughter, those animals come from flocks which either: (i) are not vaccinated against infection with Newcastle disease virus and have tested negative, during the last 14 days prior to departure, in serological tests to detect antibodies against Newcastle disease virus performed on blood samples at a level which gives 95 % confidence of detecting infection at 5 % prevalence; or (ii) are vaccinated against infection with Newcastle disease virus and have tested negative, during the last 14 days prior to departure, in a test to detect the presence of Newcastle disease virus, performed at a level which gives 95 % confidence of detecting infection at 5 % prevalence;
(c) in the case of day-old chicks, they: (i) are not vaccinated against infection with Newcastle disease virus; (ii) come from hatching eggs satisfying the conditions in point (d); (iii) come from a hatchery where working practice ensures that such hatching eggs are incubated at completely separate times and locations from hatching eggs not satisfying the conditions in point (d);
(d) in the case of hatching eggs of poultry, they: (i) are not vaccinated against infection with Newcastle disease virus; (ii) come from flocks which are: either not vaccinated against infection with Newcastle disease virus; or vaccinated against infection with Newcastle disease virus using inactivated vaccines; or vaccinated against infection with Newcastle disease virus using live vaccines that satisfy the criteria in Annex VI and vaccination has taken place at least 30 days before the collection of the hatching eggs.
(a) each of the kept ungulates and poultry subjected to those assembly operations is moved to their final place of destination in another Member State at the latest within 20 days after the date of leaving the establishment of origin; (b) the period of time between the date of departure of each of the kept ungulates and poultry from its establishment of origin and the date of its departure from the establishment approved for assembly operations in the Member State of origin to another Member State shall be no longer than 14 days.
(a) the establishment or epidemiologically separate animal accommodation areas within the establishment are emptied of animals and cleaned and disinfected at regular intervals not exceeding 14 days of uninterrupted occupation; (b) the tyres of the means of transport, from which animals are unloaded or onto which animals are loaded, are disinfected before leaving the establishment.
1. have been kept in a confined establishment and are transported to a confined establishment in the Member State of destination in accordance with the requirements in Article 64(1); or 2. come from an establishment other than a confined establishment and are transported to a confined establishment in the Member State of destination in accordance with the requirements of Article 63(2)(b).
(a) the animals and the hives of origin do not show signs of American foulbrood, infestation with Aethina tumida (Small hive beetle) or infestation withTropilaelaps spp. ;(b) they come from an apiary situated in the centre of a circle of at least: (i) 3 km radius, where American foulbrood has not been reported during the last 30 days prior to departure and which is not restricted due to an outbreak of American foulbrood; (ii) 100 km radius, where infestation with Aethina tumida (Small hive beetle) has not been reported and which is not restricted due to a suspected case or the confirmed occurrence of infestation withAethina tumida (Small hive beetle) unless a derogation is provided for in Article 49;(iii) 100 km radius, where infestation with Tropilaelaps spp. has not been reported and which is not restricted due to a suspected case or confirmed occurrence of infestation withTropilaelaps spp..
(a) in the apiary of origin infestation with Aethina tumida (Small hive beetle) has not been reported and that apiary is situated at a distance of at least 30 km from the limits of a protection zone of at least 20 km in radius established by the competent authority around a confirmed occurence of infestation withAethina tumida (Small hive beetle);(b) the apiary of origin is not located in a zone restricted by protective measures established by the Union due to the confirmed occurence of infestation with Aethina tumida (Small hive beetle);(c) the apiary of origin is situated in an area where annual surveillance for the detection of infestation with Aethina tumida (Small hive beetle) by the competent authority is ongoing to provide a confidence level of at least 95 % of detecting infestation withAethina tumida (Small hive beetle) if at least 2 % of the apiaries were infested;(d) the apiary of origin is inspected every month during the production season by the competent authority with negative results to provide a confidence level of at least 95 % of detecting infestation with Aethina tumida (Small hive beetle) if at least 2 % of the hives were infested;(e) they are caged individually with a maximum of 20 accompanying attendants.
(a) they come from a Member State or zone thereof with the status free from infestation with Varroa spp. ;(b) they are protected from infestation with Varroa spp. during transport.
(a) they do not show signs of infestation with Aethina tumida (Small hive beetle);(b) they come from an establishment situated in the centre of a circle around the establishment of at least 100 km radius, where infestation with Aethina tumida (Small hive beetle) has not been reported and which is not restricted due to a suspected case or confirmed occurrence of infestation withAethina tumida (Small hive beetle). These requirements shall not apply to bumble bees from environmentally isolated production establishments moved in accordance with Article 52.
(a) they have been bred isolated in separate epidemiological units with each colony in a closed container which was new or cleaned and disinfected before use; (b) regular surveys on the epidemiological unit carried out in accordance with written standard operating procedures has not detected the infestation with Aethina tumida (Small hive beetle) within the epidemiological unit.
(a) the animals are individually identified: either (i) in accordance with Article 70 of Delegated Regulation (EU) 2019/2035; or (ii) by a clearly readable tattoo applied before 3 July 2011 ;
(b) the animals are accompanied by an individual identification document as provided for in Article 71 of Delegated Regulation (EU) 2019/2035, and: (i) the identified animal comes from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure, and has received a complete primary course of anti-rabies vaccination at least 21 days prior to movement, or has been re-vaccinated against rabies in accordance with the validity requirements set out in Part 1 of Annex VII. This requirement shall not apply to dogs, cats and ferrets moved in accordance with Article 54(1) and (2); (ii) in case of dogs, they have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(1) of Annex VII and, where applicable, in case of dogs, cats or ferrets for other diseases in accordance with Part 2(3) of Annex VII within the required period set out therein prior to entering a Member State or zone thereof eligible to require the application of those measures. This requirement shall not apply to dogs, cats and ferrets moved in accordance with Article 54(2);
(c) animals that are assembled after leaving their establishment of origin, are assembled in assembly centres of dogs, cats and ferrets approved in accordance with Article 10 of Delegated Regulation (EU) 2019/2035.
(a) the Member State of destination has authorised such movements in general and has informed the public on a dedicated website that such movements are authorised; and (b) one of the following conditons is fulfilled: (i) the animal health certificate referred to in Article 86 is complemented by a declaration of the operator which states that from birth until the time of departure the animals have had no contact with kept terrestrial animals under suspicion of infection with rabies virus or wild animals of listed species for infection with rabies virus; or (ii) it can be established from the identification document of the mother, on whom the animals referred to in this paragraph still depend, that, before their birth, the mother received an anti-rabies vaccination which complied with the validity requirements set out in Part 1 of Annex VII.
(a) the animals are individually identified: either (i) in accordance with Article 70 of Delegated Regulation (EU) 2019/2035; or (ii) by a clearly readable tattoo applied before 3 July 2011 ;
(b) the animals are accompanied by an individual identification document as provided for in Article 71 of Delegated Regulation (EU) 2019/2035 which documents that (i) the identified animal has received a complete primary course of anti-rabies vaccination at least 21 days prior to departure, or has been re-vaccinated against rabies in accordance with the validity requirements set out in Part 1 of Annex VII. This provision shall not apply to dogs, cats and ferrets moved in accordance with the conditions in Article 56. (ii) in case of dogs, they have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(1) of Annex VII and where applicable, in case of dogs, cats or ferrets for other diseases in accordance with of Part 2(3) of Annex VII within the required period set out therein prior to entering a Member State or zone thereof eligible to require the application of those measures.
(a) the Member State of destination has authorised such movements in general and has informed the public on a dedicated website that such movements are authorised; and (b) one of the following conditions is fulfilled: (i) the animal health certificate referred to in Article 86 is complemented by a declaration of the pet keeper which states that from birth until the time of departure the animals have had no contact with kept terrestrial animals under suspicion of infection with rabies virus or wild animals of listed species for infection with rabies virus; or (ii) it can be established from the identification document of the mother, on whom the animals referred to in this paragraph still depend, that, before their birth, the mother received an anti-rabies vaccination which complied with the validity requirements set out in Part 1 of Annex VII.
(a) the animals are either individually identified or identified as a group of animals of the same species kept together during the movement to destination; (b) the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure, (c) the animals have received a complete primary course of anti-rabies vaccination at least 21 days prior to departure, or have been re-vaccinated against rabies in accordance with the validity requirements set out in Part 1 of Annex VII; (d) in case of canidae, the animals have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(2) of Annex VII within the required period set out therein prior to entering a Member State or zone thereof eligible to require the application of those measures;(e) insofar as measures were adopted pursuant to Regulation (EU) 2016/429 for an infection other than rabies listed for carnivores or certain carnivore species, the animals of the species included in those measures have been subjected to the risk-mitigation measures in accordance with of Part 2(3) of Annex VII for those carnivore species within the required period set out therein prior to entering a Member State or zone thereof eligible to require the application of those measures to animals belonging to those carnivore species.
(a) a confined establishment; or (b) an establishment where these animals are kept as fur animals as defined in point (1) of Annex I to Commission Regulation (EU) No 142/2011 Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that Directive (OJ L 54, 26.2.2011, p. 1 ).
(a) the animals have been continuously resident in a registered or a confined establishment since hatching or for at least 21 days prior to departure; (b) the animals come from flocks which show no clinical sign or suspicion of listed diseases relevant for the species; (c) the animals show no clinical signs or suspicion of listed diseases relevant for the species; (d) in case the animals have entered the Union from a third country or territory or zone thereof, they have been quarantined in accordance with the requirements for entry into the Union in the approved quarantine establishment of destination in the Union; (e) in the case of pigeons, the animals are vaccinated against infection with Newcastle disease virus and come from an establishment where vaccination against infection with Newcastle disease virus is carried out; (f) the relevant requirements related to vaccination as provided for in Articles 61 and 62.
(a) the conditions provided for in paragraph 1 are fulfilled; (b) the animals come from an establishment on which avian chlamydiosis has not been confirmed during the last 60 days prior to departure and which in case avian chlamydiosis has been confirmed during the last 6 months prior to departure has applied the following measures: (i) infected birds and birds likely to be infected have received treatment; (ii) following the completion of the treatment, they have been found negative to laboratory testing for avian chlamydiosis; (iii) after the completion of the treatment, the establishment has been cleaned and disinfected; (iv) at least 60 days have elapsed from the completion of the cleaning and disinfection referred to in point (iii);
(c) in case the animals have been in contact with captive birds from establishments on which avian chlamydiosis has been diagnosed during the last 60 days prior to departure, they are found negative to laboratory testing for avian chlamydiosis performed at least 14 days after contact; (d) the animals are identified in accordance with Article 76 of Delegated Regulation (EU) 2019/2035.
(a) they come from a registered or confined establishment; (b) they come from flocks which have been kept in a registered or confined establishment; (c) they come from flocks which show no clinical signs or suspicion of listed diseases relevant for the species; (d) they fulfil the relevant requirements related to vaccination as provided for in Articles 61 and 62.
(a) in the case of captive birds: (i) the animals are not vaccinated against infection with Newcastle disease virus; (ii) the animals have been isolated for 14 days prior to departure, at either the establishment of origin under the supervision of an official veterinarian or in an approved quarantine establishment, where: no captive birds have been vaccinated against infection with Newcastle disease virus during the last 21 days prior to departure; no other birds were introduced during the last 21 days prior to departure; no vaccination has been carried out in the quarantine establishment;
(iii) the animals have tested negative, during the last 14 days prior to departure, to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95 % confidence of detecting infection at 5 % prevalence;
(b) in the case of hatching eggs of captive birds, they: (i) are not vaccinated against infection with Newcastle disease virus; (ii) come from flocks which are: either not vaccinated against infection with Newcastle disease virus; or vaccinated against infection with Newcastle disease virus using inactivated vaccines; or vaccinated against infection with Newcastle disease virus using live vaccines that satisfy the criteria in Annex VI and vaccination has taken place at least 30 days before the collection of the hatching eggs.
(a) the animals are subjected to quarantine for a period appropriate for the diseases listed for the species to be moved and in any case of at least 30 days and during this period they are kept: either (i) prior to their movement, in an approved quarantine establishment or in quarantine facilities of another confined establishment; or (ii) after their movement, in a quarantine facility of the confined establishment of final destination;
(b) the animals show no clinical signs or suspicion of diseases listed for the species at the time of movement; (c) the animals fulfil the requirements for identification laid down in Delegated Regulation (EU) 2019/2035 relevant for the species; (d) the animals fulfil the requirements for vaccination, treatment or testing laid down in this Regulation applicable for the movement of the animals.
(a) in the case of movement within a Member State, by the competent authority of that Member State, or (b) in the case of movement to another Member State, by an agreement of the competent authority of Member State of origin and the competent authority of Member State of destination.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; or (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) they provide the competent authority in the Member State where the travelling circus or animal act is situated with an itinerary of their intended movement to another Member State at least 10 working days before departure; (b) the movement document referred to in Article 77 of Delegated Regulation (EU) 2019/2035 accompanying all animals to be moved is duly updated, and (i) the individual identification document for each dog, cat and ferret to be moved, referred to in Article 71 of Delegated Regulation (EU) 2019/2035, is duly completed with the information referred to in Article 53(b)(i) and (ii); (ii) the identification document for the group of kept birds to be moved, referred to in Article 79 of Delegated Regulation (EU) 2019/2035, is duly updated.
(c) during the last 12 months prior to departure: (i) bovine, ovine, caprine, camelid and cervid animals have been subjected to a test for infection with Brucella abortus, B. melitensis andB. suis with one of the diagnostic methods provided for in Part 1 of Annex I, with negative results;(ii) bovine, caprine and cervid animals have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) with one of the diagnostic methods provided for in Part 1 of Annex I, with negative results;(iii) pigeons have been vaccinated against infection with the Newcastle disease virus;
(d) all the animals of travelling circuses and animal acts were inspected by the official veterinarian during the period of 10 working days prior to departure of the travelling circus and animal act and were found clinically healthy for the listed diseases as applied to listed species or to categories of animals.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; or (b) without a disease-free status and without an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) the travelling circus or animal act is not subject to any animal health restriction relating to a disease listed for the species of an animal kept in the travelling circus and animal act; (b) the animal health requirements set out in Article 65 are complied with; (c) all the identification documents accompanying the animals during the movement of the travelling circus and animal act are duly updated and the animals fulfil the requirements for vaccination, treatment or testing laid down in this Regulation applicable for the movement of the relevant species.
(a) the captive birds stay in that establishment for a maximum period of 12 hours; (b) at the time of collecting, the establishment only keeps captive birds intended to the relevant exhibition; (c) all captive birds collected in the establishment come directly from registered or approved establishments in which they are continuously kept and in which they fulfill the conditions set out in Article 59.
(a) the entry into the exhibition of animals is limited to captive birds registered in advance for the participation in the exhibition; (b) the entry into the exhibition of birds originating from establishments situated in the Member State where the exhibition takes place does not jeopardise the health status of birds participating in the exhibition by either (i) requiring the same health status for all captive birds participating in the exhibition; or (ii) keeping the captive birds originating from the Member State where the exhibition takes place on separate premises or enclosures apart from captive birds originating from other Member States;
(c) a veterinarian (i) carries out identity checks on captive birds participating in the exhibition prior to their entry in the exhibition; (ii) monitors the clinical conditions of the birds upon entry into and during the exhibition.
(a) the birds are accompanied by an animal health certificate, issued either by the competent authority of the Member State of origin in accordance with Article 71(1) or by that of the Member State of the exhibition. The latter authority shall issue the animal health certificate based on official information provided in the certificate issued by the competent authority of the Member State of origin; (b) the movement takes place within the period of validity of the certificate issued by the competent authority of the Member State of origin; (c) the birds have not been in contact with birds of a lower health status during the exhibition.
(a) the birds are accompanied by the animal health certificate issued by the competent authority of the Member State of the exhibition, and completed based on official information provided in the certificate issued by the competent authority of the Member State of origin in accordance with Article 71(1); (b) the movement takes place within the period of validity of the certificate issued by the competent authority of the Member State of origin; (c) the birds have not been in contact with birds of a lower health status during the exhibition; (d) if the exhibition takes place in a Member State or zone thereof not having the status free from infection with Newcastle disease virus without vaccination, birds of galliformes species are not moved to a Member State or zone thereof having the status free from infection with Newcastle disease virus without vaccination, except if all birds of galliformes species of the exhibition comply with the requirements of Article 62, point (a).
(a) the competent authority of the Member State of destination established the conditions based on the requirements referred to in points (b) and (c) and has informed the Commission and the other Member States that such movements are authorised; (b) the animals kept and moved on the respective territories of the Member State of origin and of the Member State of destination fulfil at least the animal health requirements for movement of kept equine animals to other Member States, and in particular the specific animal health requirements laid down in Article 22; (c) the competent authority of the Member State of origin fulfils the condition, established by the competent authority of the Member State of destination, for the traceability of the animals moved and notifies the competent authority of the Member State of destination about the intention of using the derogation.
(a) in case of ovine animals except uncastrated male ovine animals, in Article 15(1) and (2); (b) in case of caprine animals, in Article 15(1) and (3); (c) in case of uncastrated male ovine animals, in Article 15(1), (2) and (4); (d) in Article 17 where applicable.
(a) in Article 15(1)(a), (b) and (d) to (h); (b) in either Article 15(1)(c) or Article 16; (c) in Article 17 where applicable.
(a) shall be issued for an individual equine animal; or (b) may be issued for a consignment of equine animals (i) dispatched directly to another Member State without undergoing assembly operations; or (ii) transported either directly or after undergoing an assembly operation to a slaughterhouse for immediate slaughter in another Member State.
(a) in the case of breeding poultry and productive poultry, in Article 34 and in Articles 41 and 42 where applicable for the specific category of poultry; (b) in the case of poultry for slaughter, in Article 35 and in Articles 41 and 42 where applicable for the specific category of poultry; (c) in the case of day-old chicks, in Article 36 and in Articles 41 and 42 where applicable for the specific category of poultry; (d) in the case of less than 20 heads of poultry other than ratites, in Article 37 and in Articles 41 and 42 where applicable for the specific category of poultry.
(a) in case of hatching eggs of poultry, except those referred to in points (b) and (c), in Article 38, and in Articles 41 and 42 where applicable for the specific category of eggs; (b) in case of less than 20 hatching eggs of poultry other than ratites, in Article 39 and in Articles 41 and 42 where applicable for the specific category of eggs; (c) in case of specified pathogen-free eggs of poultry, in Article 40.
(a) the documentary, identity and physical checks and examinations referred to in Article 91(1) are carried out before issuing the first animal health certificate referred to in Articles 73 to 80 either (i) in the establishment of origin, where the animals are destined for direct movement to an establishment approved for assembly operations in the Member State of passage; or an assembly operation on a means of transport in the Member State of origin in order to be moved directly to another Member State;
or (ii) in an establishment approved for assembly operations, where the animals have been assembled in the Member State of origin for dispatch to another Member State; or (iii) in an establishment approved for assembly operations in a Member State of passage, in case the animals have been subjected to an assembly operation in such a Member State;
(b) the animal health certificate referred to in Articles 73 to 80 is completed based on official information: (i) available to the certifying official veterinarian who carried out the checks and examinations referred to in point (a)(i) and (ii) in the Member State of origin; or (ii) provided in the first or second animal health certificate referred to in Articles 73 to 80 available to the certifying official veterinarian who carried out the checks and examinations referred to in point (a)(iii) in the Member State of passage, where one is visited.
(i) the animals comply at least with the requirements in accordance with this Chapter for the movement of kept ungulates or poultry intended for slaughter in the Member State where the exit point is located; and (ii) in case of animals of the species listed for infection with Bluetongue virus (serotypes 1-24), the animals comply at least with Article 33 when the exit point is located in a Member State or zone thereof with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24).
(a) in relation to kept ungulates, an identity check and a clinical examination of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (b) in relation to breeding poultry, productive poultry and less than 20 heads of poultry other than ratites, a documentary check of the health and production records kept at the establishment, an identity check of the animals of the consignment and a clinical inspection of the flock of origin and of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (c) in relation to poultry intended for slaughter, a documentary check of the health and production records kept at the establishment, an identity check of the animals of the consignment and a clinical inspection of the flock of origin for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (d) in relation to day-old chicks, a documentary check of the health and production records kept at the establishment of the flock of origin for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (e) in relation to captive birds: (i) an identity check of the animals of the consignment; (ii) a documentary check of the health and production records kept at the establishment and a clinical inspection of the flock of origin and of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (iii) for captive birds moved to an exhibition in another Member State from a single registered establishment pursuant to Article 67(2): identity and physical checks of the captive birds and a documentary check of health and production records of the registered or approved establishment of origin and of a declaration by the operator of that establishment attesting that: the captive birds presented for certification have been continuously resident in the establishment of origin since hatching or for at least the last 21 days prior to their departure; the flock of origin does not present abnormal mortalities with an undetermined cause; and within the last 48 hours, the birds of the flock of origin have not shown clinical signs or suspicion of listed diseases relevant for the species;
(f) in relation to hatching eggs of poultry, a documentary check of the health and production records kept at the establishment of the flock of origin and where applicable the records kept at the hatchery of dispatch, an identity check of the hatching eggs and either (i) a clinical inspection of the flock of origin for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; or (ii) monthly health inspection visits of the health status of the flock of origin and an evaluation of its current health status as assessed by up-to-date information supplied by the operator;
(g) in relation to hatching eggs of captive birds, a documentary check of the health and production records kept at the establishment, an identity check of the hatching eegs and a clinical inspection of the flock of origin for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (h) in relation to honeybees and bumble bees an identity check and either (i) a visual examination of the animals, their packaging and any accompanying feed or other material for the purpose of detection of occurrence of American foulbrood, Aethina tumida (Small hive beetle) andTropilaelaps spp. for honeybees orAethina tumida (Small hive beetle) for bumble bees;or (ii) in relation to queen honeybees to be certified under derogation provided for in Article 49, a documentary check of the records of the monthly health inspection during the production season. a visual examination of their individual cages for the purpose of verification of the maximum number of attendants per cage and a visual examination of the animals, their packaging and any accompanying feed or other material for the purpose of detection of occurrence of American foulbrood, Aethina tumida (Small hive beetle) andTropilaelaps spp. ;
(i) in relation to primates, a documentary check of the health records, an identity check and a clinical examination, and where this is not possible, a clinical inspection, of the animal(s) of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (j) in relation to dogs, cats, ferrets, a documentary check of the individual identification document provided for in Article 71 of Delegated Regulation (EU) 2019/2035, and in relation to dogs, cats, ferrets and other carnivores, an identity check and a clinical examination, and where this is not possible, a clinical inspection, of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species; (k) in relation to terrestrial animals from a confined establishment moving to a confined establishment in another Member State, a documentary check of the health records, an identity check and a clinical examination, and where this is not possible, a clinical inspection, of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed diseases relevant for the species.
(a) within the last 24 hours before departure from the establishment of origin, or where applicable the establishment approved for assembly operations, in relation to kept ungulates except equine animals; (b) within the last 48 hours or on the last working day before departure from the establishment of origin, in relation to equine animals; (c) within the last 48 hours before departure from the establishment of origin, in relation to breeding poultry, productive poultry, less than 20 heads of poultry other than ratites and captive birds; (d) within the last 5 days before departure from the establishment of origin, in relation to poultry intended for slaughter; (e) within the last 24 hours before departure from the establishment of origin in relation to day-old chicks; (f) in relation to hatching eggs of poultry: (i) within the last 72 hours before departure of the hatching eggs from the establishment of origin, in the case of the documentary checks, the identity checks, the clinical inspection of the flock of origin and the evaluation of its current health status as assessed by up-to-date information supplied by the operator; (ii) within the last 31 days before departure of the hatching eggs from the establishment of origin, in the case of monthly health inspection visits of the flock of origin;
(g) within the last 48 hours before departure from the establishment of origin, in relation to hatching eggs of captive birds: (h) within the last 48 hours before departure from the establishment of origin, in relation to honeybees and bumble bees and within the last 24 hours before departure from the establishment of origin, in relation to queen honeybees to be certified under derogation; (i) within the last 48 hours before departure from the establishment of origin, in relation to primates; (j) within the last 48 hours before departure from the establishment of origin, in relation to dogs, cats, ferrets and other carnivores; (k) within the last 48 hours before departure from the establishment of origin, in relation to terrestrial animals from a confined establishment to a confined establishment in another Member State.
(a) the equine animal to be moved is accompanied by its single lifetime identification document as provided for in Article 114(1)(c) of Regulation (EU) 2016/429 which includes a valid validation mark issued by the competent authority, or the body to which this activity was delegated, for a period not exceeding 4 years, to document that the animal is habitually resident in an establishment recognised by the competent authority as an establishment of low health risk due to frequent animal health visits, additional identity checks and health testing and the absence of natural breeding on the establishment, except in dedicated and separated premises; or (b) the registered equine animal to be moved is accompanied by its single lifetime identification document as provided for in Article 114(1)(c) of Regulation (EU) 2016/429 which includes a valid license issued, for a period not exceeding 4 years, by the national federation of the Fédération Équestre Internationale for participation in equestrian competitions or by the competent racing authority for participation in races, and which documents at least two visits per year by a veterinarian, including those necessary to carry out regular equine influenza vaccinations and examinations required for movements to other Member States or third countries.
(a) multiple entries into other Member States; (b) the return to the establishment of departure indicated therein.
(a) points 1(a) to (d) in Part 1 of Annex VIII concerning kept terrestrial animals except bumble bees from approved environmentally isolated production establishments to be moved to another Member State; (b) part 2 of Annex VIII concerning bumble bees from approved environmentally isolated production establishments.
(a) points 1(a) to (d) in Part 1 of Annex VIII concerning kept terrestrial animals except bumble bees from approved environmentally isolated production establishments to be moved to another Member State; (b) part 2 of Annex VIII concerning bumble bees from approved environmentally isolated production establishments.
(a) all parts of their territory is covered by at least one region; (b) each designated region falls within the responsibility of a competent authority designated for animal health certification in that region; (c) the competent authority responsible for the designated region has access to IMSOC; (d) the personnel of the competent authority responsible for the designated region possess the appropriate ability and knowledge, and have received specific training, or have equivalent practical experiences in the use of IMSOC for production, handling and transmission of the information provided for in Articles 97 and 98.
(a) constructed in such a way that (i) animals cannot escape or fall out; (ii) visual inspection of the animals on the means of transport is possible; (iii) the escape of animal excrements, litter or feed is prevented or minimised; (iv) in the case of birds, the escape of feathers is prevented or minimised; (v) where necessary, the animals can be restrained or transported sedated;
(b) cleaned and disinfected immediately after every transport of animals, or any item representing an animal health risk, and, if necessary, disinfected again and in any case dried or allowed to dry before any new loading of animals.
(a) comply with the conditions in point 2(a); (b) contain only wild animals of the same species coming from the same habitat; (c) are marked to detail species and number of animals; (d) are either unused purpose-designed disposable containers to be destroyed after first use or cleaned and disinfected after use and dried or allowed to dry before any subsequent use.
(a) the majority of the animals of the consignment have been resident in the habitat of origin for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept animals of a lower health status or subject to movement restrictions for animal health reasons or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b); (b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in paragraph 1, and introduced into an establishment situated in the habitat where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment and in the habitat; (c) animals that are of listed species for the relevant diseases, come from a habitat in which the following diseases and infections have not been reported during the stipulated timeframes: (i) infection with rabies virus during the last 30 days prior to departure; (ii) infection with Brucella abortus, B. melitensis andB. suis in wild terrestrial animals of listed species for that disease during the last 42 days prior to departure;(iii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in wild terrestrial animals of listed species for that disease during the last 42 days prior to departure;(iv) infection with epizootic haemorrhagic disease virus within a radius of 150 km in wild terrestrial animals of listed species for that disease during the last 2 years prior to departure; (v) anthrax in ungulates during the last 15 days prior to departure; (vi) surra ( Trypanosoma evansi ) during the last 30 days prior to departure;
(d) when those animals belong to the families of Antilocapridae ,Bovidae ,Camelidae ,Cervidae ,Giraffidae ,Moschidae orTragulidae , the habitat of origin shall be in compliance with at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;(e) those animals are not known to have been in contact with wild terrestrial animals which did not fulfil the requirements set out in point (c) during the last 30 days prior to departure.
(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; or (b) without a disease-free status and an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.
(a) an examination of available information demonstrating that the requirements provided for in Article 101(4) are fulfilled; (b) an identity check; (c) a clinical examination, and where this is not possible, a clinical inspection of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed or emerging diseases relevant for the species.
(a) buffered Brucella antigen tests;(b) complement fixation test (CFT); (c) indirect enzyme-linked immunosorbent assay (I-ELISA); (d) fluorescence polarisation assay (FPA); (e) competitive enzyme-linked immunosorbent assay (C-ELISA).
(a) buffered Brucella antigen tests;(b) complement fixation test (CFT); (c) indirect enzyme-linked immunosorbent assay (I-ELISA); (d) fluorescence polarisation assay (FPA); (e) competitive enzyme-linked immunosorbent assay (C-ELISA).
(a) the single intradermal tuberculin test (SITT); (b) the comparative intradermal tuberculin test (CITT).
(a) gamma-interferon assay.
(a) enzyme-linked immunosorbent assay (ELISA) for trypanosomiasis; (b) card agglutination test for trypanosomiasis (CATT) at a serum dilution of 1:4.
(a) tests for blood samples: (i) agar gel immuno-diffusion test (AGID); (ii) blocking enzyme-linked immunosorbent assay (B-ELISA); (iii) indirect enzyme-linked immunosorbent assay (I-ELISA).
(b) test for milk samples: (i) indirect enzyme-linked immunosorbent assay (I-ELISA).
| Methods: | |
|---|---|
| Non-vaccinated bovine animals | BoHV-1 I-ELISA |
| gB B-ELISA | |
| Bovine animals vaccinated with a gE-deleted vaccine | gE B-ELISA |
(a) real-time reverse transcription-polymerase chain reaction (real-time RT-PCR); (b) bovine viral diarrhoea virus (BVDV) antigen detection enzyme-linked immunosorbent assay (ELISA);
(a) indirect enzyme-linked immunosorbent assay (I-ELISA); (b) blocking enzyme-linked immunosorbent assay (B-ELISA); (c) virus neutralisation.
| Methods: | |
|---|---|
| Porcine animals | Aujeszky’s disease virus (ADV) ELISA |
| Porcine animals less than 4 months old born to dams vaccinated with a gE-deleted vaccine | gE ELISA |
(a) agar gel immuno-diffusion test (AGID); (b) enzyme-linked immunosorbent assay (ELISA) for equine infectious anaemia.
(a) virus isolation test for Venezuelan equine encephalomyelitis; (b) haemagglutination inhibition test for Venezuelan equine encephalomyelitis;
(a) post-mortem inspection of all slaughtered caprine animals from the establishment; (b) post-mortem examination of fallen stock of all caprine animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons; (c) an annual animal health visit carried out by a veterinarian; (d) annual testing of all caprine animals kept on the establishment for breeding purposes, with negative results.
(a) the elements referred to in points 1(a), (b) and (c), that constitute a part of the pre-movement surveillance programme established in point 1, have been carried out on the establishment referred to in point 1 for at least 24 months, and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in caprine animals kept on that establishment has not been reported during this period;(b) the establishment is situated in a Member State or zone thereof free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in its bovine animal population.
(a) post-mortem inspection of all slaughtered camelid animals from the establishment; (b) post-mortem examination of fallen stock of camelid animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons; (c) an annual animal health visit carried out by a veterinarian; (d) annual testing of all camelid animals kept on the establishment for breeding purposes, with negative results.
(a) the pre-movement surveillance programme referred to in paragraph 1 has been carried out on the establishment for at least 24 months and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in camelid animals kept on the establishment has not been reported during this period;(b) the establishment is situated in a Member State or zone thereof free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in its bovine animal population;
(a) post-mortem inspection of all slaughtered cervid animals from the establishment; (b) post-mortem examination of fallen stock of cervid animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons; (c) an annual animal health visit carried out by a veterinarian; (d) annual testing of cervid animals kept on the establishment for breeding purposes, with negative results.
(a) the pre-movement surveillance programme referred to in paragraph 1 has been carried out on the establishment for at least 24 months, and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in cervid animals kept on the establishment has not been reported during this period;(b) the establishment is situated in a Member State or zone thereof free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae andM. tuberculosis ) in its bovine animal population;
(a) an annual animal health visit carried out by a veterinarian; (b) if porcine animals are kept on the establishment for breeding, an annual immunological survey carried out in the porcine population of that establishment, using one of the diagnostic methods listed in Part 1(2) of Annex I, with at least a capacity to demonstrate with a 95 % level of confidence the absence of infection with Brucella abortus ,B. melitensis andB. suis with a target prevalence of 10 %.
(a) infection with Brucella abortus, B. melitensis andB. suis has not been reported in the kept porcine population for the last five years;(b) infection with Brucella abortus, B. melitensis andB. suis has not been reported in the population of wild animals of listed species for the past 5 years, and during that period of time, wild boars have been included in the targeted animal population for surveillance as provided for in Article 4 of Delegated Regulation (EU) 2020/689;(c) the Member State or zone thereof is free from infection with Brucella abortus, B. melitensis andB. suis in its bovine, ovine and caprine populations.
(a) infection with Salmonella Pullorum,S. Gallinarum andS. arizonae ;(b) avian mycoplasmosis ( Mycoplasma gallisepticum and M. meleagridis ).
(a) for breeding poultry, productive poultry and poultry intended for slaughter, the animals must have tested negative in serological and/or bacteriological tests for the diseases under point 1 within 21 days preceding the time of loading for dispatch; (b) for hatching eggs and day-old chicks, the flock of origin must have tested negative in serological tests and/or bacteriological tests for the diseases under point 1 within 21 days preceding the time of loading for dispatch at a level which gives 95 % confidence of detecting infection at 5 % prevalence; (c) if the animals have been vaccinated against infection with any serotype of Salmonella or Mycoplasma, only bacteriological testing must be used. The confirmation method must be capable of differentiating between live vaccinal strains and field strains.
(a) less than 0,4 if not less than 107 EID50 (50 % Embryo Infectious Dose) are administrated to each bird in the ICPI test; or(b) less than 0,5 if not less than 108 EID50 are administered to each bird in the ICPI test.
(a) the name and address of the consignor and the consignee; (b) the name and address of the establishment of dispatch, and (i) where the establishment of dispatch is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of dispatch is a registered establishment, the unique registration number of that establishment;
(c) the name and address of the establishment of destination, and (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination a registered establishment, the unique registration number of that establishment;
(d) the species and category of animals and identification, where required; (e) information on the animal health situation and additional guarantees in relation to: (i) the Member State or zone of origin; (ii) the establishment and flock of origin of the animals, including test results where applicable; (iii) the animals to be dispatched, including test results or vaccinations where applicable;
(f) the date and place of issue and period of validity of the animal health certificate, the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.
(a) the name and address of the consignor and the consignee; (b) the name and address of the establishment of dispatch, and (i) where the establishment of dispatch is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of dispatch is a registered establishment, the unique registration number of that establishment;
(c) the name and address of the establishment of destination, and, (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination a registered establishment, the unique registration number of that establishment;
(d) the category of hatching eggs; (e) information allowing identification of hatching eggs: (i) the species and identification, where required, of the animals from which they originate; (ii) the marking applied on the hatching eggs, where required; (iii) the place and date of their collection;
(f) information on the animal health situation and additional guarantees in relation to: (i) the Member State or zone thereof of origin; (ii) the establishment and flock of origin, including test results where applicable; (iii) the animals from which hatching eggs were collected, including test results where applicable; (iv) the hatching eggs to be dispatched;
(g) the date and place of issue and the period of validity of the animal health certificate and the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.
(a) the name and address of the consignor and the consignee; (b) the place where animals were captured and loaded for dispatch; (c) the place of destination, and (i) where the place of destination is the habitat, the place where animals are intended to be unloaded; or (ii) where the establishment of destination is a registered establishment, the unique registration number of that establishment;
(d) the species and category of animals; (e) the date and place of issue and period of validity of the animal health certificate, the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.
(a) the name and address of the consignor and the consignee; (b) the name, address and unique approval number of the establishment of dispatch; (c) the name and address of the establishment of destination, and (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination is a registered establishment, the unique registration number of that establishment;
(d) the species, category and quantity and size of colonies; (e) the date of dispatch.
(a) one night per week during the month before the expected beginning and during the month before the expected end of the vector-free period; and (b) one night per month during the vector-free period.
(a) it has appropriate physical barriers at entry and exit points; (b) openings shall be vector screened with mesh of appropriate gauge which shall be impregnated regularly with an approved insecticide according to the manufacturers’ instructions; (c) vector surveillance and control shall be carried out within and around the vector protected establishment; (d) measures shall be taken to limit or eliminate breeding sites for vectors in the vicinity of the vector protected establishment; and (e) standard operating procedures shall be in place, including descriptions of back-up and alarm systems, for operation of the vector protected establishment and transport of animals to the place of loading.